These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 29717819)
41. Nanostructures as promising tools for delivery of antimicrobial peptides. Brandelli A Mini Rev Med Chem; 2012 Jul; 12(8):731-41. PubMed ID: 22512554 [TBL] [Abstract][Full Text] [Related]
43. Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: a review. Ong R; Cornish J; Wen J Biometals; 2023 Jun; 36(3):709-727. PubMed ID: 36512300 [TBL] [Abstract][Full Text] [Related]
44. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Puri A; Loomis K; Smith B; Lee JH; Yavlovich A; Heldman E; Blumenthal R Crit Rev Ther Drug Carrier Syst; 2009; 26(6):523-80. PubMed ID: 20402623 [TBL] [Abstract][Full Text] [Related]
46. Liposomal drug delivery systems: from concept to clinical applications. Allen TM; Cullis PR Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225 [TBL] [Abstract][Full Text] [Related]
47. Compositional tuning of epoxide-polyetheramine "click" reaction toward cytocompatible, cationic hydrogel particles with antimicrobial and DNA binding activities. Tang S; Huang L; Daniels-Mulholland RJ; Dlugosz E; Morin EA; Lenaghan S; He W Acta Biomater; 2016 Oct; 43():292-302. PubMed ID: 27403884 [TBL] [Abstract][Full Text] [Related]
48. Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery. Liu Y; Xie X; Chen H; Hou X; He Y; Shen J; Shi J; Feng N Nanomedicine; 2020 Oct; 29():102237. PubMed ID: 32534047 [TBL] [Abstract][Full Text] [Related]
49. Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems. Madkhali OA Molecules; 2022 Feb; 27(5):. PubMed ID: 35268643 [TBL] [Abstract][Full Text] [Related]
51. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation. Devrim B; Kara A; Vural İ; Bozkır A Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346 [TBL] [Abstract][Full Text] [Related]
52. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy. Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713 [TBL] [Abstract][Full Text] [Related]
53. Role of cationic group structure in membrane binding and disruption by amphiphilic copolymers. Palermo EF; Lee DK; Ramamoorthy A; Kuroda K J Phys Chem B; 2011 Jan; 115(2):366-75. PubMed ID: 21171655 [TBL] [Abstract][Full Text] [Related]
54. Synthesis of Novel Thiazole Derivatives Bearing β-Amino Acid and Aromatic Moieties as Promising Scaffolds for the Development of New Antibacterial and Antifungal Candidates Targeting Multidrug-Resistant Pathogens. Malūkaitė D; Grybaitė B; Vaickelionienė R; Vaickelionis G; Sapijanskaitė-Banevič B; Kavaliauskas P; Mickevičius V Molecules; 2021 Dec; 27(1):. PubMed ID: 35011308 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of microbial growth by silver nanoparticles synthesized from Fraxinus xanthoxyloides leaf extract. Rafiq A; Zahid K; Qadir A; Khan MN; Khalid ZM; Ali N J Appl Microbiol; 2021 Jul; 131(1):124-134. PubMed ID: 33251642 [TBL] [Abstract][Full Text] [Related]